Results 181 to 190 of about 110,880 (279)
Implementing genetic tests: infertility and newborn bloodspot screening
Marleen E. Jansen
openalex +2 more sources
CD147/Basigin: From Integrative Molecular Hub to Translational Therapeutic Target
This review conceptualizes CD147 as a fundamental “Energy‐Structure Coupler,” physically bridging metabolic flux (via MCTs) with morphogenetic plasticity (via integrins/MMPs) to drive cancer, infection, and autoimmunity. Addressing the “specificity paradox” that limits current translation, the authors chart a strategic roadmap—spanning logic‐gated ...
Xiang‐Min Yang +2 more
wiley +1 more source
Evaluating Georgia's Cystic Fibrosis Newborn Screening Algorithm to Inform Improvement Recommendations. [PDF]
Truitt B +8 more
europepmc +1 more source
Newborn screening conditions: What we know, what we do not know, and how we will know it [PDF]
Harvey L. Levy
openalex +1 more source
“Time Is Brain” – for Cell Therapies
The concept that “time is brain” extends to stem cell therapy for stroke. Evidence across preclinical and clinical studies indicates that delivery timing shapes graft survival, integration, and efficacy by matching the evolving post‐stroke microenvironment.
Hao Yin +4 more
wiley +1 more source
Impact of Newborn Screening on Survival and Developmental Outcome in Classic Isovaleric Aciduria: A Meta-Analysis. [PDF]
Reischl-Hajiabadi AT +8 more
europepmc +1 more source
This review systematically summarizes recent advances in self‐powered flexible sensing and energy storage systems based on piezoelectric nanogenerators (PENGs). It highlights their fundamental mechanisms, structural designs, and applications in health monitoring, e‐skin, and tactile sensing. The integration of PENGs with supercapacitors or batteries is
Wu‐Lin Xin +8 more
wiley +1 more source
Next-Generation Sequencing for Cystic Fibrosis: Florida Newborn Screening Experience. [PDF]
Green DM +12 more
europepmc +1 more source
Newborn screening: new developments, new dilemmas [PDF]
Nicola Kerruish, Stephen P. Robertson
openalex +1 more source
Compared to untargeted therapy, the targeted nanocarrier, Angiopep‐2‐conjugated Lipid Nanoparticle (A‐LNP) loaded with TGN‐020 (TGN), selectively accumulated in stroke‐injured regions. It suppressed local aquaporin‐4 (AQP4) overexpression, thereby alleviating cerebral edema and hypoperfusion while preserving global glymphatic clearance.
Lei Jin +18 more
wiley +1 more source

